MTOR and neoplasm: MLN0128 (also called INK128, sapanisertib, TAK‐228) is a pan‐mTOR inhibitor that has potent anti‐tumor effects in PIK3CA‐mutant colorectal cancer and CD44‐high HCC xenografts.84, 85